October 6, 2020
NOT-AR-18-008 - Revision: NIAMS Only Accepts Clinical Trial Applications Proposing Mechanistic Studies for Clinical Trial Parent R01 and R21 Announcements (Rescinded)
PA-20-183 - Research Project Grant (Parent R01 Clinical Trial Required)
PA-20-194 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
The purpose of this Notice is to announce NIAMS continued participation in the NIH Research Project Grant (Parent R01 Clinical Trial Required) and the NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required) Funding Opportunity Announcements (FOAs), and to clarify the types of applications that may be submitted to NIAMS in response to these FOAs and subsequent reissues.
NIAMS will only accept applications in response to the NIH Parent R01 (Clinical Trial Required) and NIH Parent R21(Clinical Trial Required) FOAs that include:
Examples of types of applications eligible for acceptance under the NIH Parent R01 (Clinical Trial Required) and NIH R21 (Clinical Trial Required) FOAs may include:
Examples of types of applications that NIAMS will not accept under the NIH Parent R01 (Clinical Trial Required) and NIH Parent R21 (Clinical Trial Required) FOAs include, but are not limited to:
Please note, applications submitted in response to the NIH Parent R01 (Clinical Trial Required) and NIH Parent R21 (Clinical Trial Required) FOAs that do NOT include mechanistic clinical trials as defined by this policy notice will be withdrawn.
Applicants proposing a study that is not eligible for the NIH Parent R01 (Clinical Trial Required) or the NIH Parent R21 (Clinical Trial Required) based on this policy should consider submitting their application to a NIAMS clinical trial-specific funding announcement or to other clinical trial required/optional funding announcement in which NIAMS participates.
Applicants are strongly advised to consult with NIAMS program staff for guidance in determining the appropriate funding opportunity prior to submitting an application proposing any type of clinical trial.
NIAMS Clinical Trials
Email: NIAMSclinicaltrials@mail.nih.gov